Home・Aktien・Anika Therapeutics Inc

Anika Therapeutics Inc

Open

BrancheGesundheitswesen

21.48 2.33

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

20.57

Max

21.87

Schlüsselkennzahlen
By Trading Economics
Einkommen	8.4M 3.3M
Verkäufe	3M 33M
EPS	0.3
Gewinnspanne	10.147
Angestellte	235
EBITDA	8.3M 4.9M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	-0.8% downside

Dividenden
By Acuity
Nächstes Ergebnis	4. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	78M 277M
Vorheriger Eröffnungskurs	19.15
Vorheriger Schlusskurs	21.48

Nachrichtenstimmung

By Acuity

50%

171 / 340 Ranking in Healthcare

Anika Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Aug. 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12. Aug. 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11. Aug. 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10. Aug. 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7. Aug. 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6. Aug. 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5. Aug. 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4. Aug. 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3. Aug. 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31. Juli 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30. Juli 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29. Juli 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28. Juli 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27. Juli 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24. Juli 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22. Juli 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21. Juli 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20. Juli 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Peer-Vergleich

Kursveränderung

Anika Therapeutics Inc Prognose

Kursziel

By TipRanks

-0.8% Nachteil

12-Monats-Prognose

Durchschnitt 21 USD -0.8%

Hoch 21 USD

Tief 21 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Anika Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Anika Therapeutics Inc – Dist abgegeben haben.

Stimmung

By Acuity

171 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.